BAGALONI, IRENE
BAGALONI, IRENE
Dipartimento di Scienze Biomolecolari (DISB)
A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy
2017 Ruzzo, Annamaria; Galli, Fabio; Galli, Francesca; Rulli, E; Bagaloni, Irene; Lonardi, S; Bergamo, F; Ronzoni, M; Ionta, Mt; Massidda, B; Pella, N; Mucciarini, C; Labianca, R; Veltri, E; Sozzi, P; Barni, S; Nicolini, M; Biondi, E; Bramati, A; Turci, D; Buscaglia, M; Magnani, Mauro; Graziano, F.
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
2020 Ruzzo, Annamaria; Graziano, Francesco; Galli, Francesca; Galli, Fabio; Rulli, Eliana; Lonardi, Sara; Ronzoni, Monica; Massidda, Bruno; Zagonel, Vittorina; Pella, Nicoletta; Mucciarini, Claudia; Labianca, Roberto; Teresa Ionta, Maria; Bagaloni, Irene; Veltri, Enzo; Sozzi, Pietro; Barni, Sandro; Ricci, Vincenzo; Foltran, Luisa; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Lazzarelli, Silvia; Verusio, Claudio; Bergamo, Francesca; Sobrero, Alberto; Frontini, Luciano; Magnani, Mauro
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
2021 Loscocco, Federica; Visani, Giuseppe; Ruzzo, Annamaria; Bagaloni, Irene; Fuligni, Fabio; Galimberti, Sara; Di Paolo, Antonello; Stagno, Fabio; Pregno, Patrizia; Annunziata, Mario; Gozzini, Antonella; Barulli, Sara; Gabucci, Elisa; Magnani, Mauro; Isidori, Alessandro
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells.
2009 Amatori, S.; Papalini, F.; Lazzarini, R.; Donati, B.; Bagaloni, I.; Rippo, M. R.; Procopio, A.; Pelicci, P. G.; Catalano, A.; Fanelli, Mirco
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomized, phase III adjuvant TOSCA trial in high-risk colon cancer patients.
2017 Ruzzo, Annamaria; Graziano, F; Galli, F; Galli, F; Rulli, E; Lonardi, S; Ronzoni, M; Massidda, B; Zagonel, V; Pella, N; Mucciarini, C; Labianca, R; Ionta, M. T; Bagaloni, Irene; Veltri, E; Sozzi, P; Barni, S; Ricci, V; Foltran, L; Nicolini, M; Biondi, E; Bramati, A; Turci, D; Lazzarelli, S; Verusio, C; Bergamo, F; Sobrero, A; Frontini, L; Menghi, M; Magnani, Mauro
DNA demethylating antineoplastic strategies: a comparative point of view.
2010 Amatori, S.; Bagaloni, I.; Donati, B.; Fanelli, Mirco
Glycolytic competence in gastric adenocarcinomas negatively impacts on survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
2020 Ruzzo, Annamaria; Graziano, Francesco; Bagaloni, Irene; Di Bartolomeo, Maria; Prisciandaro, Michele; Aprile, Giuseppe; Ongaro, Elena; Vincenzi, Bruno; Perrone, Giuseppe; Santini, Daniele; Fornaro, Lorenzo; Vivaldi, Caterina; Tomasello, Gianluca; Loupakis, Fotios; Lonardi, Sara; Fassan, Matteo; Valmasoni, Michele; Sarti, Donatella; Lorenzini, Paola; Catalano, Vincenzo; Bisonni, Renato; Del Prete, Michela; Collina, Guido; Magnani, Mauro
Malten, a new synthetic molecule showing in vitro antiproliferative activity against tumor cells and induction of complex DNA structural alterations.
2010 Amatori, S; Bagaloni, I; Macedi, E; Formica, Mauro; Giorgi, Luca; Fusi, Vieri; Fanelli, Mirco
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
2021 Bagaloni, Irene; Visani, Axel; Biagiotti, Sara; Ruzzo, Annamaria; Navari, Mohsen; Etebari, Maryam; Mundo, Lucia; Granai, Massimo; Lazzi, Stefano; Isidori, Alessandro; Loscocco, Federica; Li, Jiejin; Leoncini, Lorenzo; Visani, Giuseppe; Magnani, Mauro; Piccaluga, Pier Paolo
Patients treated with FOLFOX-4 or XELOX chemotherapy with high-risk stage II and III colon cancer (TOSCA trial): a different impact of pharmacogenetic profile on toxicity in women and men
2018 Ruzzo, Annamaria; Galli, Francesca; Galli, Fabio; Bagaloni, Irene; Foltran, Luisa; Lonardi, Sara; Zagonel, Vittorina; Ronzoni, Monica; Massidda, Bruno; Ermacora, Paola; Mucciarini, Claudia; Verusio, Claudio; Veltri, Enzo; Sozzi, Pietro; Barni, Sandro; Damiani, Azzurra; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Graziano, Francesco
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES AFFECT THE DURATION OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS
2018 Loscocco, Federica; Visani, Giuseppe; Galimberti, Sara; Ruzzo, Annamaria; Bagaloni, Irene; Stagno, Fabio; Pregno, Patrizia; Annunziata, Mario; Gozzini, Antonella; Barulli, Sara; Magnani, Mauro; Isidori, Alessandro
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES MAY AFFECT THE LOSS OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS
2018 Loscocco, F; Visani, G; Galimberti, S; Ruzzo, A; Bagaloni, I; Stagno, F; Pregno, P; Annunziata, M; Gozzini, A; Attossico, I; Specchia, G; Falzetti, F; Barulli, S; Magnani, M; Isidori, A
Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma.
2011 Amatori, S.; Bagaloni, I.; Viti, D.; Fanelli, Mirco
Sex-Related Differences in Impact On Safety Of Pharmacogenetic Profile For Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy
2019 Ruzzo, Annamaria; Graziano, Francesco; Galli, Francesca; Galli, Fabio; Rulli, Eliana; Lonardi, Sara; Ronzoni, Monica; Massidda, Bruno; Zagonel, Vittorina; Pella, Nicoletta; Mucciarini, Claudia; Labianca, Roberto; Teresa Ionta, Maria; Bagaloni, Irene; Enzoveltri, ; Sozzi, Pietro; Barni, Sandro; Ricci, Vincenzo; Foltran, Luisa; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Lazzarelli, Silvia; Verusio, Claudio; Bergamo, Francesca; Sobrero, Alberto; Frontini, Luciano; Magnani, Mauro
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with antiangiogenic or standard chemotherapy regimens
2020 William Fischer, Nicholas; Graziano, Francesco; Bagaloni, Irene; Di Bartolomeo, Maria; Lonardi, Sara; Vincenzi, Bruno; Fornaro, Lorenzo; Ongaro, Elena; Aprile, Giuseppe; Bisonni, Renato; Prisciandaro, Michele; Gariépy, Jean; Loupakis, Fotios; Sarti, Donatella; Del Prete, Michela; Catalano, Vincenzo; Magnani, Mauro; Ruzzo, Annamaria
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with Ramucirumab-Paclitaxel or standard chemotherapy
2020 Graziano, Francesco; Fischer, Nicholas W.; Bagaloni, Irene; Di Bartolomeo, Maria; Lonardi, Sara; Vincenzi, Bruno; Perrone, Giuseppe; Fornaro, Lorenzo; Ongaro, Elena; Aprile, Giuseppe; Bisonni, Renato; Prisciandaro, Michele; Malkin, David; Gariépy, Jean; Fassan, Matteo; Loupakis, Fotios; Sarti, Donatella; Del Prete, Michela; Catalano, Vincenzo; Alessandroni, Paolo; Magnani, Mauro; Ruzzo, Annamaria
Warburg effect and tp53 mutational status in gastric cancer patients under ramucirumab-based therapy
2021 Bagaloni, Irene
XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT
2019 Visani, Giuseppe; Loscocco, Federica; Bagaloni, Irene; Ruzzo, Annamaria; Fuligni, Fabio; Graziano, Francesco; Magnani, Mauro; Isidori, Alessandro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy | 1-gen-2017 | Ruzzo, Annamaria; Galli, Fabio; Galli, Francesca; Rulli, E; Bagaloni, Irene; Lonardi, S; Bergamo, F; Ronzoni, M; Ionta, Mt; Massidda, B; Pella, N; Mucciarini, C; Labianca, R; Veltri, E; Sozzi, P; Barni, S; Nicolini, M; Biondi, E; Bramati, A; Turci, D; Buscaglia, M; Magnani, Mauro; Graziano, F. | |
| Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy | 1-gen-2020 | Ruzzo, Annamaria; Graziano, Francesco; Galli, Francesca; Galli, Fabio; Rulli, Eliana; Lonardi, Sara; Ronzoni, Monica; Massidda, Bruno; Zagonel, Vittorina; Pella, Nicoletta; Mucciarini, Claudia; Labianca, Roberto; Teresa Ionta, Maria; Bagaloni, Irene; Veltri, Enzo; Sozzi, Pietro; Barni, Sandro; Ricci, Vincenzo; Foltran, Luisa; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Lazzarelli, Silvia; Verusio, Claudio; Bergamo, Francesca; Sobrero, Alberto; Frontini, Luciano; Magnani, Mauro | |
| Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib | 1-gen-2021 | Loscocco, Federica; Visani, Giuseppe; Ruzzo, Annamaria; Bagaloni, Irene; Fuligni, Fabio; Galimberti, Sara; Di Paolo, Antonello; Stagno, Fabio; Pregno, Patrizia; Annunziata, Mario; Gozzini, Antonella; Barulli, Sara; Gabucci, Elisa; Magnani, Mauro; Isidori, Alessandro | |
| Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. | 1-gen-2009 | Amatori, S.; Papalini, F.; Lazzarini, R.; Donati, B.; Bagaloni, I.; Rippo, M. R.; Procopio, A.; Pelicci, P. G.; Catalano, A.; Fanelli, Mirco | |
| Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomized, phase III adjuvant TOSCA trial in high-risk colon cancer patients. | 1-gen-2017 | Ruzzo, Annamaria; Graziano, F; Galli, F; Galli, F; Rulli, E; Lonardi, S; Ronzoni, M; Massidda, B; Zagonel, V; Pella, N; Mucciarini, C; Labianca, R; Ionta, M. T; Bagaloni, Irene; Veltri, E; Sozzi, P; Barni, S; Ricci, V; Foltran, L; Nicolini, M; Biondi, E; Bramati, A; Turci, D; Lazzarelli, S; Verusio, C; Bergamo, F; Sobrero, A; Frontini, L; Menghi, M; Magnani, Mauro | |
| DNA demethylating antineoplastic strategies: a comparative point of view. | 1-gen-2010 | Amatori, S.; Bagaloni, I.; Donati, B.; Fanelli, Mirco | |
| Glycolytic competence in gastric adenocarcinomas negatively impacts on survival outcomes of patients treated with salvage paclitaxel-ramucirumab. | 1-gen-2020 | Ruzzo, Annamaria; Graziano, Francesco; Bagaloni, Irene; Di Bartolomeo, Maria; Prisciandaro, Michele; Aprile, Giuseppe; Ongaro, Elena; Vincenzi, Bruno; Perrone, Giuseppe; Santini, Daniele; Fornaro, Lorenzo; Vivaldi, Caterina; Tomasello, Gianluca; Loupakis, Fotios; Lonardi, Sara; Fassan, Matteo; Valmasoni, Michele; Sarti, Donatella; Lorenzini, Paola; Catalano, Vincenzo; Bisonni, Renato; Del Prete, Michela; Collina, Guido; Magnani, Mauro | |
| Malten, a new synthetic molecule showing in vitro antiproliferative activity against tumor cells and induction of complex DNA structural alterations. | 1-gen-2010 | Amatori, S; Bagaloni, I; Macedi, E; Formica, Mauro; Giorgi, Luca; Fusi, Vieri; Fanelli, Mirco | |
| Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma | 1-gen-2021 | Bagaloni, Irene; Visani, Axel; Biagiotti, Sara; Ruzzo, Annamaria; Navari, Mohsen; Etebari, Maryam; Mundo, Lucia; Granai, Massimo; Lazzi, Stefano; Isidori, Alessandro; Loscocco, Federica; Li, Jiejin; Leoncini, Lorenzo; Visani, Giuseppe; Magnani, Mauro; Piccaluga, Pier Paolo | |
| Patients treated with FOLFOX-4 or XELOX chemotherapy with high-risk stage II and III colon cancer (TOSCA trial): a different impact of pharmacogenetic profile on toxicity in women and men | 1-gen-2018 | Ruzzo, Annamaria; Galli, Francesca; Galli, Fabio; Bagaloni, Irene; Foltran, Luisa; Lonardi, Sara; Zagonel, Vittorina; Ronzoni, Monica; Massidda, Bruno; Ermacora, Paola; Mucciarini, Claudia; Verusio, Claudio; Veltri, Enzo; Sozzi, Pietro; Barni, Sandro; Damiani, Azzurra; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Graziano, Francesco | |
| POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES AFFECT THE DURATION OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS | 1-gen-2018 | Loscocco, Federica; Visani, Giuseppe; Galimberti, Sara; Ruzzo, Annamaria; Bagaloni, Irene; Stagno, Fabio; Pregno, Patrizia; Annunziata, Mario; Gozzini, Antonella; Barulli, Sara; Magnani, Mauro; Isidori, Alessandro | |
| POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES MAY AFFECT THE LOSS OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS | 1-gen-2018 | Loscocco, F; Visani, G; Galimberti, S; Ruzzo, A; Bagaloni, I; Stagno, F; Pregno, P; Annunziata, M; Gozzini, A; Attossico, I; Specchia, G; Falzetti, F; Barulli, S; Magnani, M; Isidori, A | |
| Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. | 1-gen-2011 | Amatori, S.; Bagaloni, I.; Viti, D.; Fanelli, Mirco | |
| Sex-Related Differences in Impact On Safety Of Pharmacogenetic Profile For Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy | 1-gen-2019 | Ruzzo, Annamaria; Graziano, Francesco; Galli, Francesca; Galli, Fabio; Rulli, Eliana; Lonardi, Sara; Ronzoni, Monica; Massidda, Bruno; Zagonel, Vittorina; Pella, Nicoletta; Mucciarini, Claudia; Labianca, Roberto; Teresa Ionta, Maria; Bagaloni, Irene; Enzoveltri, ; Sozzi, Pietro; Barni, Sandro; Ricci, Vincenzo; Foltran, Luisa; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Lazzarelli, Silvia; Verusio, Claudio; Bergamo, Francesca; Sobrero, Alberto; Frontini, Luciano; Magnani, Mauro | |
| TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with antiangiogenic or standard chemotherapy regimens | 1-gen-2020 | William Fischer, Nicholas; Graziano, Francesco; Bagaloni, Irene; Di Bartolomeo, Maria; Lonardi, Sara; Vincenzi, Bruno; Fornaro, Lorenzo; Ongaro, Elena; Aprile, Giuseppe; Bisonni, Renato; Prisciandaro, Michele; Gariépy, Jean; Loupakis, Fotios; Sarti, Donatella; Del Prete, Michela; Catalano, Vincenzo; Magnani, Mauro; Ruzzo, Annamaria | |
| TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with Ramucirumab-Paclitaxel or standard chemotherapy | 1-gen-2020 | Graziano, Francesco; Fischer, Nicholas W.; Bagaloni, Irene; Di Bartolomeo, Maria; Lonardi, Sara; Vincenzi, Bruno; Perrone, Giuseppe; Fornaro, Lorenzo; Ongaro, Elena; Aprile, Giuseppe; Bisonni, Renato; Prisciandaro, Michele; Malkin, David; Gariépy, Jean; Fassan, Matteo; Loupakis, Fotios; Sarti, Donatella; Del Prete, Michela; Catalano, Vincenzo; Alessandroni, Paolo; Magnani, Mauro; Ruzzo, Annamaria | |
| Warburg effect and tp53 mutational status in gastric cancer patients under ramucirumab-based therapy | 1-gen-2021 | Bagaloni, Irene | |
| XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT | 1-gen-2019 | Visani, Giuseppe; Loscocco, Federica; Bagaloni, Irene; Ruzzo, Annamaria; Fuligni, Fabio; Graziano, Francesco; Magnani, Mauro; Isidori, Alessandro |